ULURU Inc. Release: Zindaclin Licensing Collaborations Extended To Include Italy And Spain

November 22, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

DALLAS--(BUSINESS WIRE)--Nov. 22, 2005--ULURU INC. ("ULURU") who has signed a definitive merger agreement with Oxford Ventures, Inc. (OTCBB:OXFV) today announced the expansion of the European licensing of Zindaclin to include Italy and Spain.

Twitter
LinkedIn
Facebook
Email
Print

Alliances